An additional dermoscopic clue in basal cell carcinoma of the lower limb: the purpura-like pattern Marco Spadafora, Alberto Sticchi, Cristian Navarrete-Dechent, Shaniko Kaleci, Giovanni Pellacani, Caterina Longo Clinical and Experimental Dermatology, 2026 Background Dermoscopy is a critical tool for diagnosing basal cell carcinoma (BCC) and differentiating its histopathological subtypes. However, BCC on the lower limbs may present with atypical dermoscopic features, making its diagnosis challenging. Objectives To identify specific dermoscopic patterns of BCC on the lower limbs, focusing on the newly observed purpura-like pattern, and to assess how these features differ from BCCs in other anatomical sites. Methods A retrospective, single-centre study reviewed standardized polarized dermoscopic images of 478 BCCs collected between January 2011 and December 2022. Two independent dermatologists evaluated the dermoscopic images, blinded to histopathological diagnoses and anatomical sites. Statistical analysis was performed to determine correlations between dermoscopic features and BCC locations. A matched test set with dermoscopic images of skin conditions of the lower limb (control group) was then evaluated. Results A new dermoscopic pattern, a purpura-like pattern, was identified in lower-limb BCCs, in addition to other features such as dotted-glomerular vessels, shiny-white structures and small erosions. The purpura-like pattern, which appeared as peripheral, out-of-focus dots or globules on a coppery red background, was significantly associated with lower-limb BCCs (odds ratio 7.13, 95% confidence interval 5.01–10.16, P < 0.001). Dotted-glomerular vessels were also more frequent in lower-limb BCCs. In the control group, composed of 239 histologically confirmed non-BCC lower-limb lesions, the purpura-like pattern was identified in 3.8% (9/239) of lesions, including Kaposi sarcoma, acroangiodermatitis/stasis dermatitis, mycosis fungoides, viral wart and basosquamous carcinoma. Interrater agreement for pattern recognition was high (Cohen’s kappa = 0.81, P < 0.001). Conclusions The purpura-like pattern is an additional dermoscopic feature significantly associated with BCC on the lower limbs. Although not exclusive to BCCs, its presence, especially if combined with other dermoscopic criteria, may enhance diagnostic accuracy in this diagnostically challenging anatomical site. Further validation in larger, prospective studies is warranted.
Clinical, dermoscopic and confocal microscopy features of multiple primary melanomas according to pathogenic germline variant status: a retrospective, hospital-based study Marco Spadafora, Beatrice Melli, Jonida Bardhushi, Stefania Borsari, Simonetta Rosato, Stefano Giuseppe Caraffi, Chiara Cattani, Vincenza Ylenia Cusenza, Davide Nicoli, Shaniko Kaleci, Iris Zalaudek, Caterina Longo Clinical and Experimental Dermatology, 2026 Background Familial melanoma comprises approximately 10% of cutaneous melanomas. Individuals with pathogenic germline variants have a higher risk of developing multiple primary melanomas (MPMs) than individuals who lack these variants. However, differences in clinical, dermoscopic and reflectance confocal microscopy (RCM) features between variant carriers and noncarriers are not well established. Objectives To compare the clinical, dermoscopic and RCM characteristics of patients with MPMs with or without the pathogenic germline variants associated with familial melanoma. Methods This retrospective study included 45 patients with MPMs who underwent Sanger sequencing and/or custom next-generation sequencing (NGS) panels between 2020 and 2023. Clinical, dermoscopic and RCM images were reviewed and compared between pathogenic germline variant-positive and pathogenic germline variant-negative groups. Results Pathogenic germline variants in moderate-risk to high-risk melanoma genes were found in 15 patients. Carriers were diagnosed at a younger age than noncarriers [mean (SD) 41.8 years (10.1) vs. 53.5 (10.4); P < 0.001], more frequently had a family history of melanoma (P = 0.02), had more melanomas arising from pre-existing naevi (P < 0.001) and less actinic damage (P = 0.05). CDKN2A carriers were younger [38.9 years (11.4) vs. 45.3 (7.8)] and had fewer melanomas [2.7 (1.3) vs. 4.1 (1.2); P = 0.05] than MITF or POT1 carriers. CDKN2A carriers had low (n = 5), medium (n = 1) or high (n = 2) naevus counts, while MITF carriers had medium (n = 1) to high (n = 4) counts. Dermoscopically, pathogenic germline variant carriers showed fewer regression structures (8.3% vs. 39.8%; P = 0.01). RCM findings indicated a nonsignificant trend toward more dendritic cell-type melanomas in noncarriers (33.9% vs. 19.4%). Conclusions Patients with MPMs who carry pathogenic germline variants demonstrate distinct clinical and imaging profiles compared with patients who do not carry these variants. These findings support personalized surveillance of individuals at high risk of developing MPMs and the integration of genetic testing into melanoma management. Further studies with larger cohorts are needed to refine genotype–phenotype associations.
Passive versus active educational interventions for nevus and melanoma classification: A randomized controlled study M. Spadafora, R. Pampena, K. Peris, L. Del Regno, L. Cornacchia, M. C. Fargnoli, C. Pellegrini, P. Quaglino, S. Ribero, P. G. Calzavara‐Pinton, M. C. Arisi, M. Mirra, M. Raucci, A. Fusco, S. Kaleci, J. Chester, G. Pellacani, C. Longo Journal of the European Academy of Dermatology and Venereology, 2026 BackgroundsPatients or family members first notice around 50% of primary melanoma lesions. Targeted educational campaigns for non‐medical individuals improve melanoma detection rates, but the most effective initiatives are unclear.ObjectivesTo compare the efficacy of passive versus active intervention for non‐medical individuals in classifying nevi and melanomas.MethodsA multicentric randomized controlled study randomly assigned subjects to receive active intervention (a dermatologist explaining basic rules for melanoma detection) or passive intervention (subject independently reading the basic rules). Subjects were asked to classify 60 clinical photos of nevi and melanomas as ‘at risk’ of malignancy and nominated the rule(s) they applied at 3 time points—before (T0), immediately following (T1), and 30 ± 2 days after (T2) the educational intervention.ResultsWe randomized 364 patients. We included in the analysis 336 subjects (female 61.3%, 156 in the passive and 180 in the active intervention group) with a mean age of 44.5 years. Overall, detection rates of lesions ‘at risk’ improved from 71.2% (T0) to 86.4% (T1). At T2, detection rates were significantly higher after active intervention (83.7% vs. 86.8%, p = 0.017). Although an overall improvement was described after both interventions, rates of correct responses according to lesion‐specific features were significantly higher in the active intervention group for lesions that met ugly duckling (UD) rule criteria at T1 and both rules (ABCDE and UD rules) criteria at T2. Correct (full or partial) rule applications were observed in 80% at T1 (40.2% and 38.4%, respectively) and at T2 (40.4% and 37.8%, respectively), with significantly higher correct rule application in the active group at T1 (p = 0.001) and T2 (p = 0.03).ConclusionsActive educational intervention is more effective than passive education in improving nevi and melanomas classification and correct rule application in non‐medical individuals, with stable performance observed over time.
Optimization of autologous adipose tissue transplantation: The impact of patient-specific and intraoperative factors on cellular viability before and after cryopreservation Valentina Pinto, Filippo Taccioli, Dario Benivegna, Shaniko Kaleci, Giorgio De Santis, Massimo Pinelli Journal of Plastic Reconstructive and Aesthetic Surgery, 2025 BACKGROUND: Autologous adipose tissue transplantation is a versatile surgical procedure used for aesthetic, reconstructive, and regenerative purposes. Cryopreservation of adipose tissue collected during liposuction reduces the need for repeated fat collection, minimizing patient discomfort while preserving volumetric and regenerative properties. There are currently no studies in the literature correlating cellular viability, before and after thawing, with patient-specific variables and collection techniques. This study investigates patient-specific factors affecting cellular viability before and after thawing to refine protocols for patient selection and tissue collection. MATERIALS AND METHODS: A retrospective analysis of 55 patients from the University Hospital Policlinico of Modena was conducted. Intraoperative factors (disinfectant used, type of anesthesia, operators, associated procedure, duration of surgery, harvesting area, quantity collected) and clinical variables (age, sex, smoking status, comorbidities, antiblastic therapy, hormonal therapy, radiation therapy, immunological therapy) were analyzed. Cell count and metabolic activity tests were performed pre- and post-cryopreservation. RESULTS: Hormonal therapy significantly correlates with reduced cellular metabolic activity and viability, both pre- and post-thawing. CONCLUSIONS: The findings underscore the need to evaluate adjuvant therapies when planning adipose tissue collection. Optimizing timing and preparation can improve graft viability, reducing resorption rates and enhancing volumizing and regenerative effects. Preoperative planning must account for the timing of hormonal and other therapies to ensure effective autologous adipose transplants with improved outcomes.
Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study M Del Monte, S Kaleci, J Chester, V Zerbato, M Remitti, A Tili, A Dessilani, I Baldisserotto, S Esperti, M D Di Trapani, G Orlando, S Casolari, A Catania, A Bedini, E Franceschini, M Sarti, C Venturelli, I Venturelli, L Rofrano, E Ricchizzi, S Di Bella, C Mussini, M Meschiari Journal of Antimicrobial Chemotherapy, 2025 Background Conflicting results exist about mortality risk of infections caused by vancomycin-susceptible Enterococcus faecium (VSEfm) and vancomycin-resistant Enterococcus faecium (VREfm). Our aim was to compare risk factors and clinical outcomes among patients with VSEfm and VREfm bloodstream infections (BSIs). Methods A retrospective, multicentre, cohort study enrolled consecutive adult patients with VSEfm and VREfm BSI diagnosis between 2018–2022. Primary outcomes were 30-day-attributable and 30-day-overall mortality. Multivariable analysis propensity-weighted adjusted for timing to active therapy, Pitt Bacteremia Score (PBS) and Charlson Comorbidity Index (CCI) were performed to identify variables independently associated with 30-day mortality. Results Overall, 446 patients were enrolled: 140 (31.4%) VREfm and 306 (68.6%) VSEfm. Comparatively, VREfm patients more frequently received inappropriate antibiotic therapy, had higher sequential organ failure assessment, PBS and BSI relapses. 30-day-attributable and 30-day-overall mortality did not differ significantly between the two groups. Independent risk factors for 30-day attributable mortality were age (HR 1.04, CI95%, 1.00–1.08, P = 0.022), corticosteroid therapy (HR 3.05, CI95%, 1.24–7.47, P = 0.014) and septic shock (HR 9.10, CI95%, 3.80–21.79, P≤0.001), and overall mortality were age (HR 1.04, CI95%, 1.02–1.05, P≤0.001.), chronic liver failure (HR 1.67, CI95%, 1.02–2.75, P = 0.04) and haematological disease (HR 2.25, CI95%, 1.28–3.94, P = 0.005). Vancomycin resistance is not an independent risk factor for mortality when data are adjusted for confounding factors. Conclusions Adjusted analyses for time to active antibiotic therapy suggest that vancomycin resistance is not an independent risk factor for overall or attributable mortality among patients with Enterococcus faecium BSI. Independent risk factors identified in this study were exclusively comorbidities, severity and corticosteroids use.
Clinical, Dermoscopic and Reflectance Confocal Microscopy Characteristics Associated With the Presence of Negative Pigment Network Among Spitzoid Neoplasms Marco Spadafora, Francesca Farnetani, Stefania Borsari, Shaniko Kaleci, Dafi Porat, Silvana Ciardo, Ignazio Stanganelli, Caterina Longo, Giovanni Pellacani, Alon Scope Experimental Dermatology, 2025 Negative pigment network (NPN) is a dermoscopic structure frequently associated with melanoma. Though commonly observed in Spitz naevi (SN) and Spitzoid melanoma (SM), its reflectance confocal microscopy (RCM) correlates have been primarily studied in non‐Spitzoid melanocytic neoplasms. This study aimed to identify clinical, dermoscopic, and RCM features associated with dermoscopic NPN in Spitzoid neoplasms and explore its histopathological correlates. We retrospectively analysed clinical, dermoscopic, and RCM images from 128 histopathologically confirmed SN and SM cases diagnosed between 2014 and 2020. Lesions were grouped by presence or absence of dermoscopic NPN, and comparisons were made across clinical, dermoscopic, and RCM features. A subset of 20 cases underwent histopathologic correlation. Of the 128 cases, 96 (74%) were SN and 32 (26%) SM. NPN was present in 58 lesions (45%)—40 SN (42%) and 18 SM (56%). NPN was associated with lesion diameter ≥ 5 mm, presence of shiny white structures, dotted vessels, and inversely associated with diffuse blue‐white veil. SMs showed higher frequencies of asymmetry, multicomponent patterns, and extensive NPN. RCM features previously linked to NPN—round or linear surface disruptions, bright suprabasal areas, and broadened interpapillary spaces—were seen in 87% of cases but did not correlate with diagnosis or dermoscopic NPN. Corresponding histologic features included keratin‐filled dells, hypergranulosis, and broadened rete ridges or infundibula. RCM correlates of dermoscopic NPN are frequently observed in Spitzoid neoplasms, independent of visible dermoscopic NPN, suggesting perceptibility may depend on contrast within dermoscopic patterns.
Correlating Optical Coherence Tomography and Other Noninvasive Imaging Features With Atrophic and Hypertrophic Skin Photoaging Stefania Guida, Silvana Ciardo, Hassan Galadari, Barbara De Pace, Marco Manfredini, Johanna Chester, Shaniko Kaleci, Ilaria Proietti, Carmen Cantisani, Simone Michelini, Camilla Chello, Camila Scharf, Caterina Longo, Steven P. Nisticò, Francesca Farnetani, Franco Rongioletti, Giovanni Pellacani International Journal of Dermatology, 2025 BackgroundAccording to morphological and clinical differences, atrophic (AP) and hypertrophic (HP) skin photoaging types have been reported. The current study examines the correlation between optical coherence tomography (OCT) and dynamic‐OCT (D‐OCT) features in subjects with skin photoaging types classified as AP, HP, or controls. Furthermore, we aim to define the correlations between OCT/D‐OCT and other noninvasive skin imaging features (standardized clinical photography and reflectance confocal microscopy [RCM]).MethodsWe explored the correlations between skin photoaging types, OCT/D‐OCT, and noninvasive skin imaging features. A total of 58 patients were clinically classified as AP (n = 17), HP (n = 24), or controls (n = 17).ResultsAP subjects showed higher D‐OCT vessel assets and vessel densities (p < 0.05) compared to HP and control subjects. A significant correlation was established between standardized clinical evidence of wrinkles and RCM collagen scores. Dermal variations in HP subjects represent the underlying substrate of wrinkles.ConclusionsDespite the limited cohort, these results contribute to the current knowledge of morphologic differences between AP and HP subjects. Treatment should consider morphologic changes according to skin photoaging phenotypes for optimal personalized medicine.
Procedural Pain Management in Patients with Cerebral Palsy Undergoing Botulinum Toxin Injection: A Systematic Review and Meta-Analysis Silvia Faccioli, Alessandro Ehsani, Shaniko Kaleci, Giulia Tonini, Ilaria Tagliani, et al. Toxins, 2025 Background: The aim of this systematic review is to investigate effectiveness and safety of sedation–analgesia techniques in controlling pain during botulinum injections in patients with cerebral palsy (CP). Methods: The Pubmed, Cinahl, and Scopus databases were searched. Inclusion criteria were as follows: cerebral palsy; any type of outcome measure regarding pain and side effects assessment; any type of studies; and English language. RoB2 and Robins-I were applied to assess the risk of bias. Tables and forest plots synthetized the findings. Results: Seventeen reports were included; most regarded pain control, and ten investigated side effects. Three were RCTs, three were controlled, and twelve were observational studies. Several techniques were used, often in combination, such as non-pharmacological approaches (clown care or virtual reality); topical anesthesia with Emla®®, vapocoolant spray, or ice; and light-to-deep sedation with inhaled nitrous oxide, intranasal fentanyl, rectal, enteral, or intravenous midazolam, or intravenous ketamine or propofol. Vomiting and oxygen desaturation were uncommon complications. Conversely, the pooled incidence of other minor side effects was 6.39% (95% CI: 1.47–14.42%) under the random-effects model, with considerable heterogeneity. Conclusions: All the techniques are safe, if administered in an appropriate setting. Deep sedation is more effective in pain control but requires an anesthetist. A combined individualized approach is preferrable. PROSPERO CRD42025639999.
Characterization of different clinical presentations of Merkel cell carcinomas and their potential prognostic implications Michela Lai, Simonetta Piana, Gabriella Brancaccio, Giulia Briatico, Marica Mirra, Margherita Raucci, Andrea Ronchi, Alessandro Zerbini, Chiara Carone, Maria Banzi, Shaniko Kaleci, Giuseppe Argenziano, Caterina Longo Clinical and Experimental Dermatology, 2025 Background Recent studies have analysed the impact of Merkel cell polyomavirus (MCPyV) on the clinical features and prognosis of patients with Merkel cell carcinoma (MCC). However, there are currently no available data on specific morphological clinical differences of MCC according to MCPyV-positive (MCPyV+) and -negative (MCPyV−) status and any possible prognostic implications of the different clinical presentations. Objectives To describe the clinicopathological characteristics of patients with MCC and the prevalence of MCPyV infection in an Italian cohort of patients and to define possible differences in clinicopathological and prognostic features among MCPyV+ and MCPyV− MCCs. Methods A retrospective, multicentre cohort study was conducted in two Italian tertiary referral centres. MCPyV presence was detected by immunohistochemistry and real-time polymerase chain reaction (RT-PCR) with two different primer sets, amplifying the viral protein (VP1) or large T antigen (LT) viral regions (VP1-PCR and LT-PCR, respectively). Clinicopathological features were compared between MCPyV+ and MCPyV− tumours and between red exophytic nodules and subcutaneous cyst-like MCCs. Results Of the 62 MCCs that were included, 43 (69%) presented as red exophytic nodules and 12 (19%) with a subcutaneous cyst-like appearance; MCPyV was detected in 25 cases (40%) by IHC, 35 (56%) by VP1-PCR and 49 (79%) by LT-PCR. No correlation was found between clinical morphology and viral status. Mortality rate was higher for MCPyV− cases (77%) than for MCPyV+ (23%) (P = 0.239) and higher for red nodules (70%) than for cyst-like lesions (59%) (P = 0.005). By multivariable analysis, age at diagnosis, Ki67 proliferation index and treatment with surgery/radiotherapy remained the only factors significantly affecting overall survival. Conclusions This study highlights the potential impact of clinical morphology of MCCs on prognosis. Subcutaneous cyst-like morphology may provide a survival benefit to the patients, regardless of MCPyV status.
Diagnostic Accuracy of Magnified Dermoscopy and Reflectance Confocal Microscopy in Assessing Melanocytic Lesions Stefania Guida, Silvana Ciardo, Shaniko Kaleci, Francesca Farnetani, Marco Spadafora, Giulia Radi, Renato Rossi, Elisa Molinelli, Sabrina Longhitano, Claudio Conforti, Carmen Cantisani, Camilla Chello, Oriana Simonetti, Anna Maria Offidani, Pietro Rubegni, Franco Rongioletti, Caterina Longo, Elisa Cinotti, Giovanni Pellacani Dermatology Practical and Conceptual, 2025
External validation of a nomogram for outcome prediction in management of medium-sized (1-2 cm) kidney stones Maria C. SIGHINOLFI, Tommaso CALCAGNILE, Marco TICONOSCO, Shaniko KALECI, Stefano DI BARI, Simone ASSUMMA, Luca SARCHI, Enrico PANIO, Riccardo FERRARI, Adele PIRO, Alberto RAGUSA, Silvia CIARLARIELLO, Rodrigo D. DA SILVA, Roberto LA ROCCA, Ester ILLIANO, Alessio PALADINI, Francesco PERSICO, Davide GIRAUDO, Enrico DE MARZO, Riccardo GRISANTI, Guglielmo MANTICA, Esteban EMILIANI, Massimo MADONIA, Michele SALVETTI, Pierfrancesco BASSI, Emanuele MONTANARI, Pierluigi BOVE, Alchiede SIMONATO, Timothy D. AVERCH, Francesco PORPIGLIA, Alessandro CALARCO, Sebastiano BRUSCHETTA, Fabio MANFERRARI, Francisco P. DAELS, Maria A. CERRUTO, Alessandro ANTONELLI, Giorgio MAZZON, Antonio CELIA, Claudio SIMEONE, Stefano ZARAMELLA, Alberto SAITA, Elisabetta COSTANTINI, Ettore MEARINI, Mauro DE DOMINICIS, Vincenzo MIRONE, Fernando J. KIM, Stefania FERRETTI, Stefano PULIATTI, Bernardo ROCCO, Salvatore MICALI Minerva Urology and Nephrology, 2024
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study Ippazio Cosimo Antonazzo, Carla Fornari, Davide Rozza, Sara Conti, Raffaella di Pasquale, Paolo Cortesi, Shaniko Kaleci, Pietro Ferrara, Alberto Zucchi, Giovanni Maifredi, Andrea Silenzi, Giancarlo Cesana, Lorenzo Giovanni Mantovani, Giampiero Mazzaglia International Journal of Infectious Diseases, 2022
In Vivo Melanoma Cell Morphology Reflects Molecular Signature and Tumor Aggressiveness Alessandra Marconi, Marika Quadri, Francesca Farnetani, Silvana Ciardo, Elisabetta Palazzo, Roberta Lotti, Anna Maria Cesinaro, Luca Fabbiani, Cristina Vaschieri, Mario Puviani, Cristina Magnoni, Shaniko Kaleci, Carlo Pincelli, Giovanni Pellacani Journal of Investigative Dermatology, 2022
Unusual dermoscopic patterns of basal cell carcinoma mimicking melanoma Eleonora Di Matteo, Riccardo Pampena, Maria A. Pizzichetta, Elisa Cinotti, Johanna Chester, Shaniko Kaleci, Marco Manfredini, Stefania Guida, Emi Dika, Elvira Moscarella, Aimilios Lallas, Zoe Apalla, Giuseppe Argenziano, Jian L Perrot, Linda Tognetti, Michela Lai, Carmen Cantisani, Vincenzo Roberti, Diletta Fiorani, Carlotta Baraldi, Leonardo Veneziano, Chryssoula Papageorgiou, Silvana Ciardo, Pietro Rubegni, Iris Zalaudek, Annalisa Patrizi, Caterina Longo, Luca Bianchi, Giovanni Pellacani, Francesca Farnetani Experimental Dermatology, 2022
Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review Stefania Fugazzaro, Angela Contri, Otmen Esseroukh, Shaniko Kaleci, Stefania Croci, Marco Massari, Nicola Cosimo Facciolongo, Giulia Besutti, Mauro Iori, Carlo Salvarani, Stefania Costi International Journal of Environmental Research and Public Health, 2022
Initial Experience and Evaluation of a Nomogram for Outcome Prediction in Management of Medium-sized (1–2 cm) Kidney Stones Salvatore Micali, Maria Chiara Sighinolfi, Andrea Iseppi, Elena Morini, Tommaso Calcagnile, Mattia Benedetti, Marco Ticonosco, Shaniko Kaleci, Luigi Bevilacqua, Stefano Puliatti, Cosimo De Nunzio, Raphael Arada, Francesco Chiancone, Davide Campobasso, Ahmed Eissa, Giulia Bonfante, Elisa Simonetti, Michele Cotugno, Riccardo Galli, Pierpaolo Curti, Luigi Schips, Pasquale Ditonno, Luca Villa, Stefania Ferretti, Franco Bergamaschi, Giorgio Bozzini, Ahmed Zoeir, Ahmed El Sherbiny, Antonio Frattini, Paolo Fedelini, Zhamshid Okhunov, Andrea Tubaro, Jaime Landman, Giampaolo Bianchi, Bernardo Rocco European Urology Focus, 2022
Folliculotropism in head and neck lentigo maligna and lentigo maligna melanoma Emi Dika, Martina Lambertini, Annalisa Patrizi, Cosimo Misciali, Federica Scarfì, Giovanni Pellacani, Victor Desmond Mandel, Francesca Di Tullio, Ignazio Stanganelli, Johanna Chester, Shaniko Kaleci, Daniela Massi, Vincenzo De Giorgi, Elisa Cinotti, Pietro Rubegni, Jean Luc Perrot, Francesca Farnetani JDDG Journal of the German Society of Dermatology, 2021
Morphological classification of melanoma metastasis with reflectance confocal microscopy F. Farnetani, M. Manfredini, S. Longhitano, J. Chester, K. Shaniko, E. Cinotti, L. Mazzoni, M. Venturini, A. Manganoni, C. Longo, L. Reggiani‐Bonetti, L. Giannetti, P. Rubegni, P. Calzavara‐Pinton, I. Stanganelli, J.L. Perrot, G. Pellacani Journal of the European Academy of Dermatology and Venereology, 2019
Ex vivo fluorescence confocal microscopy: the first application for real-time pathological examination of prostatic tissue Stefano Puliatti, Laura Bertoni, Giacomo M. Pirola, Paola Azzoni, Luigi Bevilacqua, Ahmed Eissa, Ahmed Elsherbiny, Maria C. Sighinolfi, Johanna Chester, Shaniko Kaleci, Bernardo Rocco, Salvatore Micali, Ilaria Bagni, Luca Reggiani Bonetti, Antonino Maiorana, Josep Malvehy, Caterina Longo, Rodolfo Montironi, Giampaolo Bianchi, Giovanni Pellacani BJU International, 2019
Factors affecting outcome in ocular myasthenia gravis Marco Mazzoli, Alessandra Ariatti, Franco Valzania, Shaniko Kaleci, Manuela Tondelli, Paolo F. Nichelli, Giuliana Galassi International Journal of Neuroscience, 2018
Management of rectal cancers in relation to treatment guidelines: A population-based study comparing Italian and French patients Pamela Minicozzi, Anne-Marie Bouvier, Jean Faivre, Milena Sant, M. Velten, G. Launoy, V. Bouvier, J. Faivre, A.M. Bouvier, A.S. Woronoff, M. Robaszkiewicz, A. Buémi, B. Trétarre, M. Colonna, P. Delafosse, F. Molinié, S. Bara, P. Grosclaude, M. Sant, P. Minicozzi, C. Allemani, S. Kaleci, S. Maffei, M. Ponz de Leon, A. Giacomin, E. Crocetti, A. Caldarella, M. Federico, F. Iachetta, M. Fusco, R. Tumino, L. Mangone, M. Vicentini, P. Giorgi Rossi, F. Falcini, M. Budroni, R. Cesaraccio Digestive and Liver Disease, 2014
